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Abstract
Introduction: The clinical significance of elevation of lactate levels within the reference range is not well studied.
The objective of this study was to determine the best cutoff threshold for serum lactate within the reference range
(0.01 to 2.00 mM) that best discriminated between survivors and nonsurvivors of critical illness and to examine the
association between relative hyperlactatemia (lactate above the identified threshold) and mortality.
Methods: This was a retrospective cohort study of adult patients admitted to the medical-surgical intensive care
unit (ICU) of a tertiary care academic center. Youden index was calculated to identify the best lactate cutoff
threshold that discriminated between survivors and nonsurvivors. Patients with lactate above the identified
threshold were defined as having relative hyperlactatemia. Multivariate logistic regression, adjusting for baseline
variables, was performed to determine the relationship between the above two ranges of lactate levels and
mortality. In addition, a test of interaction was performed to assess the effect of selected subgroups on the
association between relative hyperlactatemia and hospital mortality.
Results: During the study period, 2,157 patients were included in the study with mean lactate of 1.3 ± 0.4 mM,
age of 55.1 ± 20.3 years, and acute physiology and chronic health evaluation (APACHE) II score of 22.1 ± 8.2.
Vasopressors were required in 42.4%. Lactate of 1.35 mM was found to be the best cutoff threshold for the whole
cohort. Relative hyperlactatemia was associated with increased hospital mortality (adjusted odds ratio (aOR), 1.60,
95% confidence interval (CI) 1.29 to 1.98), and ICU mortality (aOR, 1.66; 95% CI, 1.26 to 2.17) compared with a
lactate level of 0.01 to 1.35 mM. This association was consistent among all examined subgroups.
Conclusions: Relative hyperlactatemia (lactate of 1.36 to 2.00 mM) within the first 24 hours of ICU admission is an
independent predictor of hospital and ICU mortality in critically ill patients.
Introduction
Hyperlactatemia (>2 mM) has been shown to be an
independent predictor of mortality in different groups
of critically ill patients [1,2], such as those with sepsis,
with or without organ failure [3-11], trauma [12-17],
and acute inflammatory response syndrome [7,18]. It
has been also used to guide management of critically
ill patients. For example, the Surviving Sepsis Cam-
paign [19] and early goal-directed therapy [20] recom-
mend resuscitation of sepsis patients with lactate >4
mM. In clinical practice, less attention is paid to
lactate levels within the reference range (≤2 mM), as
their clinical significance is not well understood. Stu-
dies have suggested that relative hyperlactatemia in
patients with septic shock has been associated with
mortality [21-23], indicating that lactate might remain
normal before and during resuscitation, thus question-
ing what is the best cutoff threshold of lactate that
should trigger resuscitation. However, data in this area
remain limited. Therefore, we sought to determine the
best cutoff threshold for serum lactate that is within
the reference range (0.01 to 2.00 mM) that best discri-
minates between survivors and nonsurvivors of critical
illness and to examine the association between relative
hyperlactatemia (lactate above the identified threshold)
and mortality.
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Methods
Design and Setting
This was a retrospective cohort study of adult patients
admitted to the medical-surgical intensive care unit
(ICU) of King Abdulaziz Medical City, a tertiary care
academic center in Riyadh, Saudi Arabia, from February
2002 until December 2010. The hospital is accredited by
the Joint Commission International. The ICU is a 21-
bed closed unit with a 24 hours/7 days in-house cover-
age by board-certified intensivists [24] and admits
around 900 patients per year. The ICU has a database
for all patients for which data was prospectively col-
lected by a full-time research physician. The study was
approved by the institutional review board of the hospi-
tal and, because of the nature of the study, consent was
waived.
Patients
All patients 18 years of age or older with measured lac-
tate levels were included in this study. We excluded
patients with readmission within the same hospitaliza-
tion and brain death on admission. The following infor-
mation were noted: age, gender, acute physiology and
chronic health evaluation (APACHE) II score [25],
admission diagnosis category as defined by the acute
physiology and chronic health evaluation (APACHE) II
system [25], chronic comorbidities, history of cirrhosis,
history of diabetes, Glasgow coma scale (GCS), presence
of sepsis on admission, mechanical ventilation require-
ment in the first 24 hours of admission, the ratio of par-
tial pressure of oxygen to the fraction of inspired oxygen
(PaO2/FiO2), requirement for vasopressors (defined as
use of any vasopressor infusion except dopamine <5 μg/
kg/min), admission bilirubin, creatinine, lactate, and
international normalized ratio (INR), ICU and hospital
length of stay (LOS), mechanical ventilation duration
(MVD), requirement for tracheostomy and renal-repla-
cement therapy (RRT), and ICU and hospital mortality.
Outcomes
Hospital mortality was the primary outcome. ICU mor-
tality, ICU and hospital LOS, MVD and requirement for
tracheostomy, and RRT were the secondary outcomes.
Measurement of lactate
Lactate was measured on admission to ICU by sending
venous or arterial blood to the hospital central labora-
tory and was measured via Abbott Laboratories, Abbott
Park, IL 60064, USA, with a limit of detection of 0.006
mM. All patients who had at least one measurement of
lactate within 24 hours of admission to ICU were
included in the analysis. For patients with multiple lac-
tate measurements, the highest value of lactate level
within the first 24 hours of ICU admission was recorded
and entered into the database, and this value was used
for analysis.
Statistical analysis
Statistical analysis software (SAS, version 9.0; SAS Insti-
tute, Cary, NC, USA) was used to analyze the data. Con-
tinuous data are presented as means with standard
deviations, and categoric data, as frequencies and per-
centages. The c2 or Student t test was used to test sig-
nificant differences between study groups, as
appropriate. Youden index was calculated to identify the
best cutoff threshold of lactate that discriminates
between survivors and nonsurvivors [26]. Patients hav-
ing serum lactate above the identified cutoff threshold
were defined as having relative hyperlactatemia and
were compared with the control group of patients with
lactate below that cutoff threshold. We also calculated
the Youden index among patients with sepsis and
patients in shock (defined as requiring vasopressors) to
determine the best cutoff in these specific groups.
To determine the association between relative hyper-
lactatemia and hospital mortality, bivariate and then
multivariate logistic regression analyses were performed.
The variables entered in the model included age, gender,
APACHE II score, admission diagnosis category, history
of cirrhosis, presence of sepsis on admission, mechanical
ventilation, vasopressor use, INR, and RRT. The vari-
ables were selected based on statistical as well as on
clinical rationales. We tested for interaction to deter-
mine the effect modification of selected subgroups on
the association between relative hyperlactatemia and
hospital mortality. These subgroups included the follow-
ing: male versus female patients; age older than 50 years
versus age younger than 50 years; sepsis versus no sep-
sis; diabetes versus no diabetes; different admission diag-
nosis categories; cirrhosis versus no cirrhosis;
mechanically ventilated versus not mechanically venti-
lated; required vasopressors versus no vasopressors;
PaFiO2 ratio >200 versus PaFiO2 ratio <200. Results
were reported as adjusted odds ratio (aOR) and 95%
confidence interval (CI). A two-sided P value <0.05 was
considered to be statistically significant.
Results
Baseline characteristics of patients with lactate within
reference range
Of 10,791 patients admitted to the ICU during the study
period, 4,538 (42.1%) had lactate levels measured within
24 hours of admission to ICU. Of those with measured
lactate, 2,157 (47.5%) patients had lactate levels within
the reference range (0.01-2.00 mM). Table 1 describes
the baseline characteristics of these patients. The mean
age was 55.1 ± 20.3 years: 37.6% of them were female
patients; APACHE II score was 22.1 ± 8.2; 22.5% had
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sepsis diagnosis on admission; 75% were mechanically
ventilated; and 42.4% were receiving vasopressors. The
mean lactate was 1.3 ± 0.4 mM. The overall ICU and
hospital mortality were 14.1% and 30.0%, respectively.
Youden index
Table 2 summarizes the sensitivities and specificities,
along with the 95% CI, for different lactate cutoff points
among patients with lactate within the reference range.
Moreover, Youden index for each of these cutoff points is
presented. The best cutoff threshold that was found to dis-
criminate between survivors and nonsurvivors was 1.35
mM, as it corresponded to the highest Youden index.
Baseline characteristics of patients with relative
hyperlactatemia
Compared with control group, patients with relative
hyperlactatemia were older, had higher APACHE II
scores, were more likely to have chronic liver disease
and sepsis on admission, were more likely to be
mechanically ventilated and to be receiving vasopressors,
and had higher INRs (Table 3).
Outcomes of patients with relative hyperlactatemia
Hospital mortality was higher in patients with relative
hyperlactatemia compared with the control group
(36.7% versus 25.3%; P < 0.0001). Similarly, ICU mortal-
ity was higher (18.4% versus 11.0%; P = 0.0003) (Table
4). On multivariate logistic regression analysis, relative
hyperlactatemia was an independent predictor of hospi-
tal mortality (aOR, 1.60; 95% CI, 1.29 to 1.98), and ICU
mortality (aOR, 1.66; 95% CI, 1.26 to 2.17) (Table 4).
Subgroup analysis
The association between relative hyperlactatemia on
hospital mortality in different subgroups is shown in
Figure 1. Relative hyperlactatemia was associated with
increased hospital mortality, which was consistent
among all subgroups, as indicated by the test of interac-
tion. Youden index calculations showed that the cutoff
threshold among patients with sepsis and those who
were in shock was not different from that of the whole
population.
Discussion
Among critically ill patients with lactate levels within
the reference range (0.01 to 2.00 mM), we found lactate
of 1.35 mM to be the best cutoff threshold that discri-
minated between survivors and nonsurvivors. Relative
hyperlactatemia was an independent predictor of hospi-
tal and ICU mortality.
The first demonstration of lactate in human blood was
in shock patients, by Johann Joseph Scherer in 1843
[27]. Subsequent work led to the demonstration that tis-
sue hypoxia was associated with increased lactate level
[27]. Elevated lactate is frequently seen in critically ill
patients and is primarily a consequence of inadequate
oxygen delivery, usually associated with significant cardi-
opulmonary compromise, as seen in cardiogenic, hypo-
volemic, and septic shock [28].
In an unstressed individual, the basal lactate concen-
tration is 1.0 ± 0.5 mM. In critically ill patients, a lactate
Table 1 Baseline characteristics of all patients with
lactate ≤ 2.00 mM
Variable N = 2,157
Age (years), mean ± SD 55.1 ± 20.3
Gender, female, number (%) 810 (37.6)
APACHE II score, mean ± SD 22.1 ± 8.2




Other medical illness 107 (5)
Nonoperative trauma 244 (11.3)
Postoperative 488 (22.6)
Chronic comorbidities, number (%)
Chronic liver disease 195 (9.2)
Chronic cardiovascular disease 438 (20.6)
Chronic respiratory disease 389 (18.3)
Chronic renal disease 331 (15.6)
Chronic immunocompromised 228 (10.7)
Cirrhosis, number (%) 160 (7.4)
Diabetes, number (%) 914 (42.4)
GCS, mean ± SD 10.4 ± 4.3
Sepsis, number (%) 485 (22.5)
Mechanical ventilation, number (%) 1,618 (75.0)
PaO2/FiO2 ratio, number (%)
<200 888/2,144 (41.4)
>200 1,256/2,144 (58.6)
Vasopressors, number (%) 915 (42.4)
Lab findings, mean ± SD
Bilirubin (μM)* 41.0 ± 98.6
Creatinine (μM)* 158.2 ± 162.2
Lactate (mM)* 1.3 ± 0.4
INR 1.4 ± 0.7
ICU LOS (days), mean ± SD 9.2 + 10.8
Hospital LOS (days), mean ± SD 52.0 ± 75.8
Mechanical ventilation duration (days), mean ± SD 7.5 ± 10.3
Tracheostomy, number (%) 403 (18.7)
RRT, number (%) 366 (17.0)
ICU mortality, number (%) 304 (14.1)
Hospital mortality, number (%) 648 (30.0)
APACHE II: acute physiology and chronic health evaluation; PaO2/FiO2, the
ratio of partial pressure of oxygen to the fraction of inspired oxygen; GCS,
Glasgow coma scale; INR, International normalized ratio; ICU, intensive care
unit; LOS, length of stay; RRT, renal replacement therapy. To convert bilirubin
to mg/dl, divide by 17.1; creatinine to μg/dl, divide by 88.4; lactate to g/dl,
divide by 0.111
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level of ≤2 mM is considered to be within the reference
range [29], and therefore, hyperlactatemia is defined as
lactate of >2 mM. A wealth of literature exists on hyper-
lactatemia (>2 mM) [2,4,6,10] but not on lactate within
the reference range.
We found that a significant percentage (47.5%) of criti-
cally ill patients who had lactate measured within 24
hours of ICU admission had an admitting lactate level of
≤2 mM, with overall hospital mortality of 30%. It has
been reported that 24% to 34% of patients with severe
sepsis and septic shock have lactate levels within the
reference range [10,22]. Trzeciak et al. [30] evaluated
1,177 patients with primary or secondary diagnosis of
infection and had serum lactate measured and found that
most (70.3%) patients had lactate of 0.0 to 2.0 mM [30].
The evidence linking lactate within the reference
range (0.01 to 2.0 mM) to mortality is also limited. We
found that relative hyperlactatemia was an independent
predictor of both hospital and ICU mortality. Nichol et
al. [31], in their prospective observational study of 7,155
consecutive critically ill patients, found that increased
admission lactate within the reference range was inde-
pendently associated with increased hospital mortality in
general critically ill patients. Trzeciak et al. [30] found
that patients with infections and lactate <2 mM had a
mortality of 15% compared with 25% for patients with
lactate 2.1 to 3.9 mM and 38% for those with lactate ≥4
mM (P < 0.001). In our study, we found that a lactate of
1.35 mM was the best cutoff threshold to discriminate
between survivors and nonsurvivors among critically ill
patients who had lactate within the reference range.
Interestingly, this cutoff threshold was similar in
patients with sepsis and also in patients with shock.
This may be of significant importance in identifying
severe sepsis early, which is one of the main targets of
sepsis-management quality-improvement initiatives.
Whether patients with relative hyperlactatemia should
be treated differently is unknown. Rivers et al. [20], in
the early goal-directed therapy study for severe sepsis or
septic shock, excluded patients with MAP >65 mm Hg
and lactate <4 mM from early intervention. The Surviv-
ing Sepsis Campaign Guidelines also recommended lac-
tate of >4 mM (even in the absence of hypotension) as
one of the criteria for initiating early-goal-directed ther-
apy [19]. Whether early intervention in patients with
relative hyperlactatemia will improve outcomes is a
question that may be intuitive but requires further
study.
Our study should be viewed in terms of its strengths
and limitations. Strengths include the analysis of
Table 2 Youden index calculation in the whole cohort of patients with lactate within the reference range
Lactate level (mM) Sensitivity 95% CI Specificity 95% CI LR+ LR- Youden
index
≥0.07 100.00 99.4-100.0 0.00 0.0-0.2 1.00 0
>0.09 100.00 99.4-100.0 0.13 0.02-0.5 1.00 0.00 0.0013
>0.1 99.85 99.1-100.0 0.20 0.04-0.6 1.00 0.78 0.0005
>0.2 99.54 98.7-99.9 0.40 0.1-0.9 1.00 1.16 -0.0006
>0.3 99.07 98.0-99.7 0.53 0.2-1.0 1.00 1.75 -0.004
>0.4 98.61 97.4-99.4 1.06 0.6-1.7 1.00 1.31 -0.0033
>0.5 97.69 96.2-98.7 2.78 2.0-3.7 1.00 0.83 0.0047
>0.6 95.52 93.6-97.0 6.76 5.5-8.1 1.02 0.66 0.0228
>0.7 92.90 90.6-94.8 12.39 10.8-14.2 1.06 0.57 0.0529
>0.8 85.96 83.0-88.5 18.82 16.9-20.9 1.06 0.75 0.0478
>0.9 79.17 75.8-82.2 25.78 23.6-28.1 1.07 0.81 0.0495
>1 70.52 66.8-74.0 36.71 34.3-39.2 1.11 0.80 0.0723
>1.1 62.35 58.5-66.1 45.79 43.3-48.3 1.15 0.82 0.0814
>1.2 57.41 53.5-61.3 54.14 51.6-56.7 1.25 0.79 0.1155
>1.3 51.08 47.2-55.0 62.16 59.7-64.6 1.35 0.79 0.1324
>1.4 41.51 37.7-45.4 69.18 66.8-71.5 1.35 0.85 0.1069
>1.5 32.87 29.3-36.6 74.82 72.5-77.0 1.31 0.90 0.0769
>1.6 25.77 22.4-29.3 80.91 78.8-82.9 1.35 0.92 0.0668
>1.7 19.44 16.5-22.7 85.22 83.3-87.0 1.32 0.95 0.0466
>1.8 11.73 9.4-14.5 89.86 88.2-91.3 1.16 0.98 0.0159
>1.9 6.02 4.3-8.1 94.76 93.5-95.8 1.15 0.99 0.0078
>2 0.00 0.0-0.6 100.00 99.8-100.0 1.00 0
CI, confidence interval.
LR+, Likelihood positive ratio = sensitivity/(1-specificity).
LR-, Likelihood negative ratio = (1-sensitivity)/specificity).
Rishu et al. Critical Care 2013, 17:R197
http://ccforum.com/content/17/5/R197
Page 4 of 7
Table 3 Baseline characteristics of patients with relative hyperlactatemia (lactate, 1.36 to 2.00 mM) compared with the






Age (years), mean ± SD 54.1 ± 20.7 56.5 ± 19.7 0.009
Gender, female, number (%) 478 (38.1) 332 (36.8) 0.54
APACHE II, mean ± SD 21.5 ± 8.0 22.8 ± 8.4 0.0004
Admitting diagnostic category, number (%)
Respiratory 324 (25.8) 213 (23.6) 0.04
Cardiovascular 312 (24.8) 267 (29.6)
Neurologic 123 (9.8) 79 (8.8)
Other medical illness 67 (5.3) 40 (4.4)
Nonoperative trauma 157 (12.5) 87 (9.7)
Postoperative 272 (21.7) 216 (24.0)
Chronic comorbidities, number. (%)
Chronic liver disease 98 (8.0) 97 (10.7) 0.02
Chronic cardiovascular disease 250 (20.8) 188 (21.1) 0.61
Chronic respiratory disease 220 (17.8) 169 (19.0) 0.51
Chronic renal disease 194 (15.7) 137 (15.4) 0.81
Chronic immunocompromised 133 (10.8) 95 (10.7) 0.93
Cirrhosis, number (%) 82 (6.5) 78 (8.7) 0.06
Diabetes, number (%) 530 (42.2) 384 (42.6) 0.87
GCS, mean ± SD 10.6 ± 4.2 10.2 ± 4.4 0.07
Sepsis, number (%) 256 (20.4) 229 (25.4) 0.006
Mechanical ventilation, number (%) 917 (73.1) 701 (77.7) 0.01
PaO2/FiO2 ratio, number (%)
<200 mm Hg 499/1247 (40.0) 389/897 (43.4) 0.12
>200 mm Hg 748/1247 (60.0) 508/897 (56.6)
Vasopressors, number (%) 508 (40.5) 407 (45.1) 0.03
Laboratory findings, mean ± SD
Bilirubin, (μM) 38.2 ± 101.4 44.9 ± 94.6 0.13
Creatinine, (μM 157.8 ± 169.3 158.8 ± 151.9 0.88
Lactate (mM) 1.0 ± 0.2 1.7 ± 0.2 <0.0001
INR 1.3 ± 0.7 1.4 ± 0.7 0.01
APACHE, acute physiology and chronic health evaluation; PaO2/FiO2, the ratio of partial pressure of oxygen to the fraction of inspired oxygen; GCS, Glasgow
Coma Scale; INR, International normalized ratio. To convert bilirubin to mg/dl divide by 17.1; creatinine to mg/dl by 88.4; lactate to mg/dl, divide by 0.111.





aOR (95% CI) P value
Hospital mortality, number (%) 317 (25.3) 331 (36.7) 1.60 (1.29-1.98) <0.0001*
ICU mortality, number (%) 138 (11.0) 166 (18.4) 1.66 (1.26-2.17) 0.0003*
ICU LOS, mean ± SD 9.1 ± 10.4 9.4 ± 11.4 * 0.49
Hospital LOS, mean ± SD 52.6 ± 71.6 51.2 ± 81.4 * 0.69
Mechanical ventilation duration mean ± SD 7.3 ± 10.3 7.8 ± 10.3 * 0.32
Tracheostomy, number. (%) 246 (19.6) 157 (17.4) 0.78 (0.62-0.98) 0.04*
RRT, number (%) 202 (16.1) 164 (18.2) 1.16 (0.92-1.45) 0.20*
ICU, Intensive care unit; LOS, length of stay; RRT, renal replacement therapy.
*Adjusted for age, gender, APACHE II score, admission diagnosis category, mechanical ventilation, cirrhosis, presence of sepsis on admission, vasopressor use, INR,
and RRT.
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prospectively collected data by a full-time research phy-
sician, large sample size, 24/7 coverage of the unit by
board-certified intensivists [24] rendering uniform care
to all patients. The lactate was measured in the central
laboratory, thus minimizing possible false readings of
various point-of-care devices because of different meth-
ods of measurements used in many ICUs [32]. As for
limitations, the study is single centered, lactate levels
were not measured in all patients, and the analysis was
performed by using a single, not serial values. Finally,
we do not have data about the interventions and medi-
cations that can affect the lactate level.
Conclusions
Relative hyperlactatemia (lactate of 1.36 to 2.00 mM)
within the first 24 hours of ICU admission is an inde-
pendent predictor of hospital and ICU mortality in criti-
cally ill patients. Further studies are required to examine
the most appropriate diagnostic and therapeutic
approach to patients with relative hyperlactatemia.
Key messages
• Among critically ill patients with lactate within the
reference range, lactate of 1.35 mM was found to be
the best cutoff threshold that discriminated between
survivors and nonsurvivors.
• Relative hyperlactatemia within the first 24 hours
of ICU admission is an independent predictor of
hospital and ICU mortality in critically ill patients.
• Association between hospital mortality and rela-
tive hyperlactatemia was consistent among all sub-
groups, including patients with sepsis and those
with shock.
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